journal article·2018-10-31Open access

Controlled release of mitomycin C from PHEMAH–Cu(II) cryogel membranes

Monireh Bakhshpour, Handan Yavuz, Adil Denizli

Abstract

Molecular imprinting technique was used for the preparation of antibiotic and anti-neoplastic chemotherapy drug (mitomycin C) imprinted cryogel membranes (MMC-ICM). The membranes were synthezied by using metal ion coordination interactions with N-methacryloyl-(l)-histidine methyl ester (MAH) functional monomer and template molecules (i.e. MMC). The 2-hydroxyethyl methacrylate (HEMA) monomer and methylene bisacrylamide (MBAAm) crosslinker were used for the preparation of mitomycin C imprinted cryogel membranes by radical suspension polymerization technique. The imprinted cryogel membranes were characterized by scanning electron microscopy (SEM), Brunauer-Emmett-Teller (BET), Fourier transform infrared spectroscopy-attenuated total reflectance (FTIR-ATR) and swelling degree measurements. Cytotoxicity of MMC-ICMs was investigated using mouse fibroblast cell line L929. Time-dependent release of MMC was demonstrated within 150 h from cryogel membranes. Cryogels demonstrated very high MMC loading efficiency (70-80%) and sustained MMC release over hours.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Protein Interaction Studies and Fluorescence Analysis · Glycosylation and Glycoproteins Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, Hacettepe University

Funding

Scientific and Technological Research Council of Turkey

References (44)

Show source-provided references
1. 10.1016/B978-0-12-813627-0.00012-010.1016/B978-0-12-813627-0.00012-0 ↗
2. 10.1016/j.jconrel.2014.03.05310.1016/j.jconrel.2014.03.053 ↗
3. 10.1016/j.addr.2013.12.00710.1016/j.addr.2013.12.007 ↗
4. 10.1016/j.ijpharm.2013.01.07110.1016/j.ijpharm.2013.01.071 ↗
5. 10.18632/oncotarget.960210.18632/oncotarget.9602 ↗
6. 10.3329/imcjms.v10i2.3111010.3329/imcjms.v10i2.31110 ↗
7. 10.1080/09205063.2017.128277210.1080/09205063.2017.1282772 ↗
8. 10.1002/aic.1177910.1002/aic.11779 ↗
9. 10.1016/j.apsusc.2016.08.10710.1016/j.apsusc.2016.08.107 ↗
10. 10.1039/c0cs00084a10.1039/c0cs00084a ↗
11. 10.1039/C6CS00061D10.1039/C6CS00061D ↗
12. 10.3109/21691401.2014.89763110.3109/21691401.2014.897631 ↗
13. 10.3109/21691401.2015.112962310.3109/21691401.2015.1129623 ↗
14. 10.3109/21691401.2012.74209910.3109/21691401.2012.742099 ↗
15. 10.1080/10826068.2015.108540010.1080/10826068.2015.1085400 ↗
16. 10.3109/21691401.2015.101180610.3109/21691401.2015.1011806 ↗
17. 10.3109/10731199.2012.71606610.3109/10731199.2012.716066 ↗
18. 10.3109/21691401.2013.86466310.3109/21691401.2013.864663 ↗
19. 10.1016/j.actbio.2011.11.00510.1016/j.actbio.2011.11.005 ↗
20. 10.1002/anie.19951812110.1002/anie.199518121 ↗
21. 10.1080/21691401.2016.117544510.1080/21691401.2016.1175445 ↗
22. 10.1016/j.colsurfb.2017.07.02310.1016/j.colsurfb.2017.07.023 ↗
23. 10.1016/j.ijpharm.2011.06.00410.1016/j.ijpharm.2011.06.004 ↗
24. 10.1016/j.addr.2004.04.00210.1016/j.addr.2004.04.002 ↗
25. 10.1016/j.talanta.2012.12.05410.1016/j.talanta.2012.12.054 ↗
26. 10.1002/jssc.20130104910.1002/jssc.201301049 ↗
27. 10.1002/mabi.20050006510.1002/mabi.200500065 ↗
28. 10.1002/jcb.2260210.1002/jcb.22602 ↗
29. 10.3109/21691401.2013.82309410.3109/21691401.2013.823094 ↗
30. 10.1039/b706654f10.1039/b706654f ↗
31. Perçin I, Baydemir G, Ergün B, et al. Macroporous PHEMA based cryogel disks for bilirubin removal. Artif Cell Nanomed B. 2013;41:171–177.
32. 10.1039/C4AN01000K10.1039/C4AN01000K ↗
33. 10.1016/j.colsurfb.2014.12.03810.1016/j.colsurfb.2014.12.038 ↗
34. 10.1080/21691401.2016.124354910.1080/21691401.2016.1243549 ↗
35. 10.1016/j.jiec.2016.10.01110.1016/j.jiec.2016.10.011 ↗
36. 10.1002/smll.20167014610.1002/smll.201670146 ↗
37. 10.3109/21691401.2016.116091310.3109/21691401.2016.1160913 ↗
38. 10.1021/ma01136210.1021/ma011362 ↗
39. 10.1021/la000170p10.1021/la000170p ↗
40. 10.1007/s00289-002-0065-410.1007/s00289-002-0065-4 ↗
41. 10.1016/j.ijpharm.2006.06.02010.1016/j.ijpharm.2006.06.020 ↗
42. 10.1080/00914037.2013.76916010.1080/00914037.2013.769160 ↗
43. 10.4236/jbnb.2012.3404810.4236/jbnb.2012.34048 ↗
44. 10.1016/j.nano.2009.05.00910.1016/j.nano.2009.05.009 ↗